Cell response to the exposure to chitosan-TPP//alginate nanogels.

Hydrophilic nanocarriers formed by electrostatic interaction of chitosan with oppositely charged macromolecules have a high potential as vectors in biomedical and pharmaceutical applications. However, comprehensive information about the fate of such nanomaterials in biological environment is lacking. We used chitosan from both animal and fungal sources to form well-characterized chitosan-pentasodium triphosphate (TPP)//alginate nanogels suitable for comparative studies. Upon exposure of human colon cancer cells (HT29 and CaCo2), breast cancer cells (MDA-MB-231 and MCF-7), glioblastoma cells (LN229), lung cancer cells (A549), and brain-derived endothelial cells (HCEC) to chitosan-(TPP)//alginate nanogels, cell type-, nanogel dosage-, and exposure time-dependent responses are observed. Comparing chitosan-TPP//alginate nanogels prepared from either animal or fungal source in terms of nanogel formation, cell uptake, reactive oxygen species production, and metabolic cell activity, no significant differences become obvious. The results identify fungal chitosan as an alternative to animal chitosan in particular if biomedical/pharmaceutical applications are intended.

[1]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[2]  G. Vandermeulen,et al.  Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery. , 2010, International journal of pharmaceutics.

[3]  J. Wilhelm,et al.  Evaluation of different methods detecting intracellular generation of free radicals , 2009, Molecular and Cellular Biochemistry.

[4]  Tao Wang,et al.  Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. , 2007, Colloids and surfaces. B, Biointerfaces.

[5]  P. Kaeuper,et al.  Vaccination of mice with chitosan nanogel‐associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites , 2011, Parasite immunology.

[6]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[7]  P Buri,et al.  Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.

[8]  J. Kjems,et al.  Chitosan/siRNA Nanoparticle-mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  K. Chennazhi,et al.  Chitosan conjugated DNA nanoparticles in gene therapy , 2010 .

[10]  M. Huggins,et al.  THE VISCOSITY OF DILUTE SOLUTIONS OF LONG-CHAIN MOLECULES, IV. DEPENDENCE ON CONCENTRATION , 1942 .

[11]  L. Juillerat-Jeanneret,et al.  Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[12]  W. Prinyawiwatkul,et al.  Physicochemical and functional properties of chitosans prepared from shells of crabs harvested in three different years , 2009 .

[13]  Xiongwei Li,et al.  TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[15]  A. Rodrigues,et al.  A validated 1H NMR method for the determination of the degree of deacetylation of chitosan. , 2003, Journal of pharmaceutical and biomedical analysis.

[16]  N. Mishra,et al.  Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. , 2008, International journal of pharmaceutics.

[17]  Tao Wang,et al.  Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.

[18]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[19]  I. Fridovich,et al.  Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. , 1998, Free radical biology & medicine.

[20]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[21]  O. Smidsrod,et al.  Solution properties of chitosans: conformation and chain stiffness of chitosans with different degrees of N-acetylation , 1993 .

[22]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[23]  O. Smidsrod,et al.  Determination of the degree of N-acetylation and the distribution of N-acetyl groups in partially N-deacetylated chitins (chitosans) by high-field n.m.r. spectroscopy. , 1991, Carbohydrate research.

[24]  R. Riguera,et al.  Optimal routine conditions for the determination of the degree of acetylation of chitosan by 1H-NMR , 2005 .

[25]  M. Alonso,et al.  Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .

[26]  H. Junginger,et al.  Preparation of coated nanoparticles for a new mucosal vaccine delivery system. , 2005, International journal of pharmaceutics.

[27]  A. Vila,et al.  Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  J. Fernandes,et al.  Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  R. Bodmeier,et al.  Preparation and Evaluation Of Drug-Containing Chitosan Beads , 1989 .

[30]  N. M. Zaki,et al.  Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation , 2009, Pharmaceutical Research.

[31]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[33]  Maria Dusinska,et al.  Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.

[34]  V. Bindokas,et al.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[36]  M. Rinaudo,et al.  Chitin and chitosan: Properties and applications , 2006 .

[37]  P. Dubruel,et al.  Poly-L-glutamic acid derivatives as vectors for gene therapy. , 2000, Journal of controlled release : official journal of the Controlled Release Society.